Martha J. Demski, Director at Adamas Pharmaceuticals Inc (ADMS), sold 2,000 shares at $5.17 ($10K) on 2021-06-07, disclosed to the SEC on 2021-06-08.
Scheduled sale ($10k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CMRX | BUY | 2022-05-17 | $16K | — | Filing → |
| ADMA | BUY | 2020-09-14 | $5K | — | Filing → |
| ADMA | BUY | 2020-08-14 | $6K | — | Filing → |